Navigating the ALS Genetic Labyrinth: The Role of MAPT Haplotypes
- PMID: 38002967
- PMCID: PMC10671552
- DOI: 10.3390/genes14112023
Navigating the ALS Genetic Labyrinth: The Role of MAPT Haplotypes
Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by wide clinical and biological heterogeneity, with a large proportion of ALS patients also exhibiting frontotemporal dementia (FTD) spectrum symptoms. This project aimed to characterize risk subtypes of the H1 haplotype within the MAPT (microtubule-associated protein tau) gene, according to their possible effect as a risk factor and as a modifying factor in relation to the age of disease onset. One hundred patients from Bulgaria with sporadic ALS were genotyped for the variants rs1467967, rs242557, rs1800547, rs3785883, rs2471738, and rs7521. Haploview 4.2 and SHEsisPlus were used to reconstruct haplotype frequencies using genotyping data from the 1000 Genomes project as controls. Genotype-phenotype correlation was investigated in the context of age of disease onset and risk of disease development. While the individual variants of the subtypes do not influence the age of onset of the disease, a correlation was found between the specific haplotype GGAGCA (H1b) and the risk of developing sALS, with results showing that individuals harboring this haplotype have a nearly two-fold increased risk of developing sALS compared to other H1 subtypes. The results from this study suggest that fine transcriptional regulation at the MAPT locus can influence the risk of ALS.
Keywords: ALS; H1 haplotype; MAPT; neurodegenerative disorders.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.Oncotarget. 2017 Jul 4;8(27):44994-45007. doi: 10.18632/oncotarget.16690. Oncotarget. 2017. PMID: 28402959 Free PMC article. Review.
-
Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.JAMA Neurol. 2018 Jul 1;75(7):860-875. doi: 10.1001/jamaneurol.2018.0372. JAMA Neurol. 2018. PMID: 29630712 Free PMC article.
-
Further validation of the association between MAPT haplotype-tagging polymorphisms and Alzheimer's disease: neuropsychological tests, cerebrospinal fluid biomarkers, and APOE genotype.Front Mol Neurosci. 2024 Sep 25;17:1456670. doi: 10.3389/fnmol.2024.1456670. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39386049 Free PMC article.
-
Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.Mov Disord. 2019 Sep;34(9):1325-1332. doi: 10.1002/mds.27773. Epub 2019 Jun 24. Mov Disord. 2019. PMID: 31234228 Free PMC article.
-
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.Alzheimers Dement. 2016 Dec;12(12):1297-1304. doi: 10.1016/j.jalz.2016.05.002. Epub 2016 Jun 7. Alzheimers Dement. 2016. PMID: 27287057 Free PMC article. Review.
Cited by
-
Genetic Modifiers of ALS: The Impact of Chromogranin B P413L in a Bulgarian ALS Cohort.Genes (Basel). 2024 Sep 12;15(9):1197. doi: 10.3390/genes15091197. Genes (Basel). 2024. PMID: 39336788 Free PMC article.
References
-
- Ghetti B., Oblak A.L., Boeve B.F., Johnson K.A., Dickerson B.C., Goedert M. Invited Review: Frontotemporal Dementia Caused by Microtubule-Associated Protein Tau Gene (MAPT) Mutations: A Chameleon for Neuropathology and Neuroimaging. Neuropathol. Appl. Neurobiol. 2015;41:24–46. doi: 10.1111/nan.12213. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous